HER2 Specific Tumor Targeting with Dendrimer Conjugated Anti-HER2 mAb-Reference-Cited by-同舟云学术

HER2 Specific Tumor Targeting with Dendrimer Conjugated Anti-HER2 mAb

Published:2006-08-15 Issue:5 Volume:17 Page:1109-1115
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Shukla Rameshwer¹,Thomas Thommey P.¹,Peters Jennifer L.¹,Desai Ankur M.¹,Kukowska-Latallo Jolanta¹,Patri Anil K.¹,Kotlyar Alina¹,Baker James R.¹

Affiliation:

1. Michigan Nanotechnology Institute for Medicine and Biological Sciences, Department of Internal Medicine, Division of Allergy, University of Michigan, 9220 MSRB III, Box 0648, Ann Arbor, Michigan 48109

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc050348p

Reference27 articles.

1. Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors

2. Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The advancements and prospective developments in anti-tumor targeted therapy;Neoplasia;2024-10

2. Targeting ferroptosis for leukemia therapy: exploring novel strategies from its mechanisms and role in leukemia based on nanotechnology;European Journal of Medical Research;2024-04-09

3. Dendrimers: promises and challenges in drug delivery;Molecular Pharmaceutics and Nano Drug Delivery;2024

4. Dendrimer-based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

5. Recent progress in nanomedicines for imaging and therapy of brain tumors;Biomaterials Science;2023